Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway

Fabrizio Benedetti, Jennifer Durando, Sergio Vighetti, Fabrizio Benedetti, Jennifer Durando, Sergio Vighetti

Abstract

Nocebo and placebo effects have been found to modulate several neurochemical systems, such as cholecystokinin, endogenous opioids, and endocannabinoids. Here we show that also the cyclooxygenase-prostaglandins pathway can be modulated by both nocebos and placebos. In fact, we found that negative expectation, the crucial element of the nocebo effect, about headache pain led to the enhancement of the cyclooxygenase-prostaglandins pathway, which, in turn, induced pain worsening. As an experimental model, we studied hypobaric hypoxia headache at high altitude in 2 populations of subjects. Whereas the experimental nocebo group received negative information by a single individual who was informed about the risk of headache, the control group did not know about the possible occurrence of headache. We found a significant increase in headache and salivary prostaglandins and thromboxane in the nocebo group compared to the control group, suggesting that negative expectations enhance cyclooxygenase activity. In addition, placebo administration to headache sufferers at high altitude inhibited the nocebo-related component of pain and prostaglandins synthesis, which indicates that the cyclooxygenase pathway can be modulated by both nocebos and placebos. Our results show for the first time how nocebos and placebos affect the synthesis of prostaglandins, which represent an important target of analgesic drugs, thus emphasizing once again the notion that placebos and drugs may use common biochemical pathways.

Keywords: Cortisol; Cyclooxygenase; Headache; Nocebo; Placebo; Prostaglandins; Thromboxane.

Copyright © 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

References

    1. Bearman PS, Moody J. Suicide and friendships among American adolescents. Am J Public Health 2004;94:89-95.
    1. Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013;93:1207-1246.
    1. Benedetti F. Responding to nocebos through observation: social contagion of negative emotions. PAIN® 2013;154:1165.
    1. Benedetti F, Amanzio M, Rosato R, Blanchard C. Non-opioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature Med 2011;17:1228-1230.
    1. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006;26:12014-12022.
    1. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful – unraveling the mechanisms of the nocebo effect. Neuroscience 2007;147:260-271.
    1. Burtscher M, Likar R, Nachbauer W, Philadelphy M. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial. BMJ 1998;316:1057-1058.
    1. Busse R, Fosterman U, Matsuda H, Pohl U. The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia. Pflügers Arch 1984;401:77-83.
    1. Cacioppo JT, Fowler JH, Christakis NA. Alone in the crowd: the structure and spread of loneliness in a large social network. J Pers Soc Psychol 2009;97:977-991.
    1. Casey ML, MacDonald PC, Mitchell MD. Despite a massive increase in cortisol secretion in women during parturition, there is an equally massive increase in prostaglandin synthesis. A paradox? J Clin Invest 1985;75:1852-1857.
    1. Chartrand TL, Lakin JL. The antecedents and consequences of human behavioral mimicry. Annu Rev Psychol 2013;64:285-308.
    1. Christakis NA, Fowler JH. The collective dynamics of smoking in a large social network. N Engl J Med 2008;358:2249-2258.
    1. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007;357:370-379.
    1. Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. PAIN® 2009;144:28-34.
    1. Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol 2004;141:580-585.
    1. Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache 2010;50:844-851.
    1. Fowler JH, Christakis NA. Cooperative behaviour cascades in human social networks. Proc Natl Acad Sci USA 2010;107:5334-5338.
    1. Fowler JH, Christakis NA. Dynamic spread of happiness in a large social network: longitudinal analysis over 20 years in the Framingham heart study. BMJ 2008;337:a2338.
    1. Fredricks KT, Liu Y, Rusch NJ, Lombard JH. Role of endothelium and arterial K+ channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol 1994;267:H580-H586.
    1. Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention and treatment. Prog Cardiovasc Dis 2010;52:467-484.
    1. Kawabata A. Prostaglandin E2 and pain—an update. Biol Pharm Bull 2011;34:1170-1173.
    1. Luke DA, Harris JK. Network analysis in public health: history, methods, and applications. Annu Rev Public Health 2007;28:69-93.
    1. Messina EJ, Sun D, Koller A, Wolin MS, Kaley G. Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle. Circ Res 1992;71:790-796.
    1. Nattero G, Allais G, De Lorenzo C, Benedetto C, Zonca M, Melzi E, Massobrio M. Relevance of prostaglandins in true menstrual migraine. Headache 1989;29:232-237.
    1. Puig-Parellada P, Plans JM, Giménez J, Sánchez J, Gaya J, Tolosa E, Obach J. Plasma and saliva levels of PGI2 and TXA2 in the headache-free period of classical migraine patients. The effects of nicardipine. Headache 1991;31:156-158.
    1. Ray CJ, Abbas MR, Coney AM, Marshall JM. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol 2002;544:195-209.
    1. Richalet J-P, Hornych A, Rathat C, Aumont J, Larmignat P, Rémy P. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol 1991;85:205-215.
    1. Singer T, Seymour B, O'Doherty J, Kaube H, Dolan RJ, Frith CD. Empathy for pain involves the affective but not sensory components of pain. Science 2004;303:1157-1162.
    1. Smith KP, Christakis NA. Social networks and health. Annu Rev Soc 2008;34:405-429.
    1. Swider K, Bąbel P. Effect of the sex of a model on nocebo hyperalgesia induced by social observational learning. PAIN® 2013;154:1312-1317.
    1. Tuca JO, Planas JM, Parellada PP. Increase in PGE2 and TXA2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache 1989;29:498-501.
    1. Vardi J, Flechter S, Alguati A, Regev I, Ayalon D. Prostaglandin-E2 levels in the saliva of common migrainous women. Headache 1983;23:59-61.
    1. Vögtle E, Barke A, Kröner-Herwig B. Nocebo hyperalgesia induced by social observational learning. PAIN® 2013;154:1427-1433.
    1. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human μ–opioid activity during pain. Proc Natl Acad Sci USA 2007;104:11056-11061.
    1. Wilson MH, Newman S, Imray CS. The cerebral effects of ascent to high altitudes. Lancet Neurol 2009;8:175-191.
    1. Zakar T, Hirst JJ, Mijovic JE, Olson DM. Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells. Endocrinology 1995;136:1610-1619.
    1. Zhu XO, Yang Z, Guo CM, Ni XT, Li JN, Ge YC, Myatt L, Sun K. Paradoxical stimulation of cyclooxygenase-2 expression by glucocorticoids via a cyclic AMP response element in human amnion fibroblasts. Mol Endocrinol 2009;23:1839-1849.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir